Perioperative Management of Celecoxib in Neurosurgery

Introduction to Bleeding Risk

• Neurosurgery represents a "very high bleeding risk" procedure where even minor bleeding can have catastrophic consequences 2
• Surgery occurs in a confined space where hematoma expansion causes immediate neurological compromise 1

Discontinuation Guidelines

• For intracranial neurosurgery or surgery in confined spaces, consider stopping celecoxib 4 days preoperatively to ensure complete resolution of any antiplatelet effects 1
• The American Society of Anesthesiologists recommends stopping celecoxib 1-4 days before neurosurgery, depending on the specific procedure and bleeding risk, although the specific guideline is not mentioned in the article, a similar recommendation can be applied 1

Management of Combined Anticoagulation

• Bleeding risk substantially increases when celecoxib is combined with anticoagulants or antiplatelet agents (aspirin, clopidogrel, warfarin, DOACs) 3
• In patients on dual therapy, manage the more potent anticoagulant/antiplatelet agent according to its specific guidelines while stopping celecoxib 1-4 days preoperatively 4

Postoperative Care

• For intracranial procedures, consider delaying resumption of celecoxib to 48-72 hours given the confined space and catastrophic consequences of postoperative hematoma 2